NVCT

Nuvectis Pharma, Inc.

$8.67-0.08 (-0.91%)
Price
MA20
Insider buy
Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5

Nuvectis Pharma, Inc. (NVCT) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.

Latest Insider Transactions

Showing 10 of 31 transactions (past 365 days)

NVCT
CSO
Award
$0
Poradosu Enrique150,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-06
NVCT
CEO
Award
$0
Bentsur Ron150,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-06
NVCT
VP
Award
$0
Carson Michael J.61,200 shares @ $0.00
Filed 2026-01-09Trade 2026-01-06
NVCT
CD&OO
Award
$0
Shemesh Shay150,000 shares @ $0.00
Filed 2026-01-09Trade 2026-01-06
NVCT
Director
Purchase
$64.2K
Kaplan Matthew L.11,000 shares @ $5.84
Filed 2025-11-06Trade 2025-11-05
NVCT
CEO
Purchase
$28.6K
Bentsur Ron5,000 shares @ $5.72
Filed 2025-11-06Trade 2025-11-05
NVCT
Director
Purchase
$75.3K
Sanchez Juan13,000 shares @ $5.79
Filed 2025-11-06Trade 2025-11-05
NVCT
10% Owner
Purchase
$457.4K
Mosseri Marlio Charles72,836 shares @ $6.28
Filed 2025-10-29Trade 2025-10-27
NVCT
10% Owner
Purchase
$215.5K
Mosseri Marlio Charles35,034 shares @ $6.15
Filed 2025-10-29Trade 2025-10-24
NVCT
10% Owner
Purchase
$284.2K
Mosseri Marlio Charles46,900 shares @ $6.06
Filed 2025-10-29Trade 2025-10-23

Want to see more transactions?

Sign up for free to unlock more insider transactions and create watchlists.

Cluster Buy Signals →All Insider Signals →Top Insider Buying →